Scott Young | VP of Corporate Communications & Investor Relations |
Michael Clayman | CEO |
Melissa Layman | Chief Commercial Officer |
David Arkowitz | CFO |
Fred Driscoll | Incoming CFO |
Elliot Wilbur | Raymond James |
Madhu Kumar | Goldman Sachs |
Serge Belanger | Needham & Company |
Evan Hua | BMO Capital Markets |
Patrick Trucchio | H.C. Wainwright |
François Brisebois | Oppenheimer |
Carl Byrnes | Northland Capital Management |
Daniel Busb | RBC Capital Markets |
Bruce Jackson | The Benchmark Company |
Good afternoon, ladies and gentlemen, and welcome to the Flexion Therapeutics' First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
We will be facilitating a question-and-answer session at the end of today's call. [Operator Instructions] I'll now turn the call over to Scott Young, Flexion's Vice President of Corporate Communications and Investor Relations.
Good afternoon.